Arvinas, Inc. (ARVN) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the ARENA's first quarter 2026 earnings call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please provide that today's conference has been recorded. I would like to hand the conference over to your first speaker today, Jeff Boyle, head of investment relations. Please go ahead. Good morning, everyone. Thank you for joining us. Earlier today, we issued a press release with our first quarter of 2026 financial results, which is available in the investor and media section of our website at arvenis.com. Joining us on the call today, we have Randy Keel, our president and CEO, Noah Berkowitz, our chief medical officer, Angelica Casey, our Chief Scientific Officer, and Andrew Sayek, our Chief Financial Officer. Before we begin, I'll remind you that today's discussion contains forward-looking statements that involve risks, uncertainties, and assumptions. These risks and uncertainties are outlined in today's press release and in the company's recent filings with the Securities and Exchange Commission, which I urge you to read. Our actual results may differ materially from what is discussed on today's call. A replay of the call as well as today's press release and an updated corporate deck will be available on the investor and media section of our website. And now I'll turn the call over to Randy Thiel. Randy? Thanks, Jeff. And thank you all for joining us today. Since stepping into the role as CEO earlier this year, my appreciatio...